Company news

Sonoma Pharmaceuticals, Inc. news in 2026

Sonoma Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA

August 6, 2026

Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution

June 30, 2026

Annual Report for Fiscal Year Ending 03-31, 2026 (Form 10-K)

June 16, 2026

Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering

April 23, 2026

Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

March 23, 2026

Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin

March 17, 2026

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results

February 10, 2026

Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development

January 28, 2026

Decks in 2026